"Doctors say they will need to operate soon on Tulane safety Devon Walker, who is in stable condition after fracturing his spine in an apparent head-to-head collision with a teammate during a weekend game in Tulsa".
Again the FDA's "foot dragging" on getting In Vivo's scaffold technology to clinical trial is delaying getting this device's potential to those who need it most---the above is a case in point!!!
Gentlemen: Your concern for young Mr Walker, and humanity in general, is certainly appreciated,
however, the FDA doesn't deal in emotions. They do giive certain priorities where it is warrented.
NVIV has been given priority. I'm afraid that is the best we can expect.
Stocks are one thing but someone with a life changing injury like this is another entirely. I saw Devon Walker's accident when it happened and the first thing that came to mind was scaffold technology. This is where the business side of things takes a back seat to the humanitarian necessity of making this technology available. The FDA should be ashamed for keeping this technology out of the reach of those who would benefit from it.